Product information
Product Overview
Retatrutide 30mg is supplied as a single-vial lyophilised research peptide for in-vitro laboratory and analytical use only. Retatrutide is a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, investigated for its role in metabolic signalling, energy homeostasis, and adipose tissue regulation. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.
Research Peptides | Research Use Disclaimer | Concentration Calculator
Technical Specifications
| Property | Value |
|---|---|
| Purity | ≥99% (third-party) |
| Molecular Formula | C₂₄₄H₃₉₄N₆₈O₇₂ |
| Molecular Weight | 5765.5 g/mol |
| CAS Number | 2381089-83-2 |
| Form | Lyophilised Powder |
| Appearance | White Lyophilised Powder |
Batch-specific third-party documentation is available. View COA & Lab Testing.
Research Applications
- GIP/GLP-1/glucagon receptor triple agonism studies
- Metabolic signalling pathway investigation in vitro
- Energy homeostasis and adipose tissue regulation research
- Comparative incretin receptor pharmacology assays
- Lipid metabolism and lipolysis modelling in cell culture
- Multi-receptor agonist activity and selectivity profiling